| Name | Title | Contact Details |
|---|---|---|
Ken Washington |
chief technology and innovation officer | Profile |
Chris Reed |
Vice President, Product Security | Profile |
Chris Snavely |
Information Technology Program Director - BRM (Service and Repair) | Profile |
Laura Groschen |
Chief Information Officer, Business Partner Services | Profile |
Rebecca Gottlieb |
Vice President of Research and Technology | Profile |
Acutus Medical is committed to pioneering a breakthrough technology to optimize the treatment strategies for complex cardiac arrhythmias by developing innovative, safe, efficacious, and cost-effective solutions for individuals suffering from these complex cardiac arrhythmias. Our mission is to develop and market a platform technology of safe, cost-effective and clinically advanced tools for the minimally invasive diagnosis (mapping) of complex arrhythmias (Atrial Fibrillation and Ventricular Tachycardia) that enable Physicians to optimize treatments and expand the ablation/therapeutic markets. In the pursuit of our mission, we will conduct all of our activities with the highest integrity and strive to become the world’s most valued company within the markets we serve to patients, customers, colleagues, investors, business partners, employees, and the communities in which we work and live.
Simavita is a medical device company operating in the digital healthcare sector that has developed an innovative world first solution for the management of urinary incontinence, with a focus on the elderly. Our flagship product is the SIM™ platform technology, an instrumented Incontinence assessment application that provides evidence based Incontinence management care plans to the residential aged care market. Simavita is committed to continuously innovating and expanding its core SIM™ platform technology to improve the level of Incontinence care, create efficiencies, promote effective utilisation of our society`s finite resources and enhance the dignity of care for our ageing population.
Brown and Toland Physicians Services Organization is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NuGEN Technologies is a San Carlos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.